Aurora Cannabis (ACB) Competitors $5.98 +0.44 (+7.94%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends ACB vs. PRAX, AVDL, ANIP, BCAX, CALT, BCYC, COLL, IMTX, AUTL, and AVBPShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Praxis Precision Medicines (PRAX), Avadel Pharmaceuticals (AVDL), ANI Pharmaceuticals (ANIP), Bicara Therapeutics (BCAX), Calliditas Therapeutics AB (publ) (CALT), Bicycle Therapeutics (BCYC), Collegium Pharmaceutical (COLL), Immatics (IMTX), Autolus Therapeutics (AUTL), and ArriVent BioPharma (AVBP). These companies are all part of the "pharmaceutical products" industry. Aurora Cannabis vs. Praxis Precision Medicines Avadel Pharmaceuticals ANI Pharmaceuticals Bicara Therapeutics Calliditas Therapeutics AB (publ) Bicycle Therapeutics Collegium Pharmaceutical Immatics Autolus Therapeutics ArriVent BioPharma Aurora Cannabis (NASDAQ:ACB) and Praxis Precision Medicines (NASDAQ:PRAX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, community ranking, earnings, analyst recommendations and dividends. Does the media refer more to ACB or PRAX? In the previous week, Praxis Precision Medicines had 3 more articles in the media than Aurora Cannabis. MarketBeat recorded 4 mentions for Praxis Precision Medicines and 1 mentions for Aurora Cannabis. Praxis Precision Medicines' average media sentiment score of 0.70 beat Aurora Cannabis' score of 0.00 indicating that Praxis Precision Medicines is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Praxis Precision Medicines 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of ACB or PRAX? 47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 67.8% of Praxis Precision Medicines shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 2.7% of Praxis Precision Medicines shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has stronger valuation & earnings, ACB or PRAX? Aurora Cannabis has higher revenue and earnings than Praxis Precision Medicines. Aurora Cannabis is trading at a lower price-to-earnings ratio than Praxis Precision Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$200.35M1.64-$48.62M-$0.70-8.54Praxis Precision Medicines$1.77M702.06-$123.28M-$10.25-6.83 Which has more risk & volatility, ACB or PRAX? Aurora Cannabis has a beta of 1.87, meaning that its share price is 87% more volatile than the S&P 500. Comparatively, Praxis Precision Medicines has a beta of 2.67, meaning that its share price is 167% more volatile than the S&P 500. Does the MarketBeat Community believe in ACB or PRAX? Aurora Cannabis received 342 more outperform votes than Praxis Precision Medicines when rated by MarketBeat users. However, 70.91% of users gave Praxis Precision Medicines an outperform vote while only 59.44% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformAurora CannabisOutperform Votes38159.44% Underperform Votes26040.56% Praxis Precision MedicinesOutperform Votes3970.91% Underperform Votes1629.09% Is ACB or PRAX more profitable? Aurora Cannabis has a net margin of -14.46% compared to Praxis Precision Medicines' net margin of -6,987.01%. Aurora Cannabis' return on equity of -7.00% beat Praxis Precision Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-14.46% -7.00% -4.88% Praxis Precision Medicines -6,987.01%-61.47%-55.85% Do analysts rate ACB or PRAX? Praxis Precision Medicines has a consensus target price of $145.67, suggesting a potential upside of 108.04%. Given Praxis Precision Medicines' higher possible upside, analysts clearly believe Praxis Precision Medicines is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Praxis Precision Medicines 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 SummaryPraxis Precision Medicines beats Aurora Cannabis on 10 of the 18 factors compared between the two stocks. Ad Investing Daily2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.Click here. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$327.94M$1.27B$5.04B$8.43BDividend YieldN/AN/A7.52%4.16%P/E Ratio-8.5439.97130.7816.68Price / Sales1.648.691,683.1176.29Price / Cash24.2515.5336.9133.54Price / Book0.732.094.604.98Net Income-$48.62M-$51.67M$115.00M$224.39M7 Day Performance0.50%-0.28%-0.26%1.30%1 Month Performance8.73%12.89%5.73%4.90%1 Year Performance22.04%9.44%33.72%26.31% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.7099 of 5 stars$5.98+7.9%N/A+22.0%$327.94M$200.35M-8.541,073Upcoming EarningsPRAXPraxis Precision Medicines3.1747 of 5 stars$69.99-0.1%$143.44+104.9%+316.8%$1.24B$2.45M-6.83110Upcoming EarningsAVDLAvadel Pharmaceuticals2.6936 of 5 stars$15.47+19.8%$24.71+59.8%+36.6%$1.24B$27.96M-13.22154Gap UpHigh Trading VolumeANIPANI Pharmaceuticals4.8104 of 5 stars$57.25-2.2%$77.33+35.1%-14.4%$1.23B$486.82M48.93642Upcoming EarningsBCAXBicara Therapeutics1.6195 of 5 stars$23.68-0.1%$41.00+73.1%N/A$1.23BN/A0.0032Analyst ForecastNews CoverageCALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180Upcoming EarningsBCYCBicycle Therapeutics2.7285 of 5 stars$23.45-2.5%$44.56+90.0%+51.1%$1.14B$26.98M-6.15240Earnings ReportCOLLCollegium Pharmaceutical4.0824 of 5 stars$34.14-1.5%$42.60+24.8%+47.4%$1.12B$566.77M13.23210Upcoming EarningsPositive NewsIMTXImmatics1.7592 of 5 stars$9.10-1.4%$17.50+92.3%-2.7%$1.10B$58.44M-10.22260Upcoming EarningsAUTLAutolus Therapeutics2.8443 of 5 stars$3.37-15.8%$8.70+158.2%-18.3%$1.06B$1.70M-2.91330Upcoming EarningsHigh Trading VolumeAVBPArriVent BioPharma0.3271 of 5 stars$29.34-6.8%$36.80+25.4%N/A$1.06BN/A0.0040 Related Companies and Tools Related Companies Praxis Precision Medicines Competitors Avadel Pharmaceuticals Competitors ANI Pharmaceuticals Competitors Bicara Therapeutics Competitors Calliditas Therapeutics AB (publ) Competitors Bicycle Therapeutics Competitors Collegium Pharmaceutical Competitors Immatics Competitors Autolus Therapeutics Competitors ArriVent BioPharma Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACB) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
